Serum |
(i) established sample banks often composed of serum aliquots (retrospective studies), |
(i) presence of various products derived from coagulation cascade, |
(i) use standardized collection protocol, |
(ii) proteins and peptides that “survive” to the clotting procedure exhibit a stability that can be exploited in routine clinical applications. |
(ii) biomarker with poor stability during coagulation process will not be detected in serum, |
(ii) keep sample during 1 hour at RT to allow clotting process before centrifugation, |
|
(iii) possible influence of the disease on coagulation process. |
(iii) preserve on ice after clotting. Aliquoting and freezing (−80°C) cannot be done immediately. |
|
Plasma |
(i) more rapidly processed than serum (interesting for emergency diagnosis), |
(i) interference with chip surface (i.e. heparin tube), |
(i) use standardized collection protocol, |
(ii) larger final volume of fluid after processing than with serum, |
(ii) sample dilution in citrate tube, |
(ii) carefully choose the type of anticoagulants (EDTA tubes are preferable), |
(iii) more stable than serum due to the inhibition of coagulation cascade. |
(iii) possible interference of EDTA with protein binding on IMAC surface, |
(iii) use platelet-poor plasma, |
|
(iv) SELDI-TOF spectra less rich in peaks number and intensity than serum. |
(iv) centrifuge, aliquot and freeze (−80°C) as soon as possible. If not possible, keep at RT to avoid cold platelet activation. |
|
Dry blood |
(i) medical staff not needed for collection, |
(i) elution step to recover sample from filter paper. |
(i) keep dry specimens at RT for 3–4 hours in horizontal position, |
(ii) low blood volume necessary, |
|
(ii) store at −20°C. |
(iii) easy storage and transport. |
|
|
|
Saliva |
(i) easy and noninvasive sampling, |
(i) low volume collected, |
(i) always collect with the same method (stimulated or not) and at the same moment of the day, |
(ii) medical staff not needed for collection, |
(ii) presence of many proteases and unspecific materials such as food residues or microorganisms, |
(ii) centrifuge to remove insoluble material, aliquot and freeze at −80°C. |
|
(iii) level of certain plasma proteins are not reflected in saliva. |
|
|
Urine |
(i) easy and noninvasive collection, |
(i) fluctuation of protein concentration overtime and according to renal integrity, |
(i) use standardized collection protocol, |
(ii) medical staff not needed for collection, |
(ii) presence of salts and proteins in low concentration. |
(ii) concentrate the samples, |
(iii) obtained in large volume. |
|
(iii) centrifuge, aliquot and freeze at −80°C, |
|
|
(iv) normalization with creatinine content. |